In brief, what’s happening at Penn—whether it’s across campus or around the world.
The Accelerator is an annual fixture of the Center for Health Care Innovation, but there was no class in 2020. Most of the Center’s staff had been dispatched on various projects to battle COVID-19. So the fact that a 2021 class is being selected is a welcoming sign of the approach of normalcy.
FULL STORY AT Penn Medicine News →
Administrative professionals may largely work out of the spotlight, but their efforts ensure that every unit and department is stocked, staffed, and scheduled. Several members of the hospital system’s administrative staff here are highlighted for their dedication.
FULL STORY AT Penn Medicine News →
In the Serve Saturday outreaches, volunteers gather in underserved areas in the city to lead a variety of programs, ranging from giving out groceries, paying for gas and offering SEPTA key cards, to cleaning public spaces. With support from a Penn Medicine CAREs grant, Serve Saturday will be able to extend their services to the Port Richmond area in North Philadephia.
FULL STORY AT Penn Medicine News →
A team of neuroscientists led by Michael Jacob Kahana, Edmund J. and Louise W. Kahn Term Professor of Psychology and and Director of the Computational Memory Lab, are developing and testing new therapeutics for treating memory loss in patients with traumatic brain injury, alongside basic research on electrophysiological biomarkers of memory at Penn.
FULL STORY AT Penn Arts & Sciences →
Monoclonal antibodies, laboratory-made proteins that effectively boost the immune system’s ability to fight the COVID-19 virus, is shown to significantly reduce the risk of hospitalization or death in people age 65 or older, and those with certain chronic medical conditions, such as diabetes, heart disease, or obesity. Monoclonal antibody infusion received an emergency use authorization from the U.S. Food and Drug Administration in late 2020, following successful clinical trials at Penn Medicine and other institutions.
FULL STORY AT Penn Medicine News →
Penn’s Gene Therapy Program will use Discovery Labs’ suburban campus for a portion of its expanding research operations focused on the development of genetic medicines for rare and orphan diseases, as well as acquired and pandemic infectious diseases, such as COVID-19.
FULL STORY AT Penn Medicine News →
The Penn Neuro COVID Clinic aims to assess and treat long-haul COVID patients suffering from neurological symptoms, focusing on patients who previously tested positive for COVID-19 and experience symptoms related to cognition, headache, vertigo, and brain fog.
FULL STORY AT Penn Medicine News →
Research from a Penn Medicine study finds that suppressing detectable hepatitis B infection with the use of antiretroviral therapy cut the risk of developing liver cancer by 58%. These findings suggest that the best care for individuals with HIV and detectable hepatitis B includes sustained hepatitis B suppression with antiretroviral therapy.
FULL STORY AT Penn Medicine News →
Launched in 2019, the Wildlife Futures Program is a science-based, wildlife health partnership with Penn’s School of Veterinary Medicine serving to strengthen the resilience of the Commonwealth’s 480 species of wild birds and mammals. It was honored this spring, alongside the Pennsylvania Game Commission, which established the partnership, by The Northeast Wildlife Administrators Association of the Northeast Association of Fish and Wildlife Agencies.
FULL STORY AT Penn Vet →
The issue of which health care structures and practices might change as a result of the COVID-19 pandemic was the central theme of a panel of experts that was part of the two-day University of Pennsylvania 2021 Alumni Weekend.
FULL STORY AT Leonard Davis Institute →
